Taken together, these results account for a role of GATA3 as a negative regulator of MPA-induced cell proliferation through prevention of cyclin A2 upregulation, and demonstrate the requirement of GATA3 downregulation for progestin-driven breast cancer growth. The gene discussed is CCNA2; the disease is breast cancer.